An ethanolic extract ofArtemisia scopariainhibits lipolysis in vivo and has antilipolytic effects on murine adipocytes in vitro
- 1 November 2018
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 315 (5) , E1053-E1061
Abstract
An ethanolic extract of Artemisia scoparia (SCO) has metabolically favorable effects on adipocyte development and function in vitro and in vivo. In diet-induced obese mice, SCO supplementation significantly reduced fasting glucose and insulin levels. Given the importance of adipocyte lipolysis in metabolic health, we tested hypothesized that SCO modulates lipolysis in vitro and in vivo. Free fatty acids and glycerol were measured in the sera of mice fed a high-fat diet with or without SCO supplementation. In cultured 3T3-L1 adipocytes, the effects of SCO on lipolysis were assessed by measuring glycerol and free fatty acid release. Microarray analysis, qPCR, and immunoblotting were used to assess gene expression and protein abundance. We found that SCO supplementation of a high-fat diet in mice substantially reduces circulating glycerol and free fatty acid levels, and observed a cell-autonomous effect of SCO to significantly attenuate TNFα (tumor necrosis factor alpha)-induced lipolysis in cultured adipocytes. Although several pro-lipolytic and anti-lipolytic genes were identified by microarray analysis of subcutaneous and visceral adipose tissue from SCO-fed mice, regulation of these genes did not consistently correlate with SCO's ability to reduce lipolytic metabolites in sera or cell culture media. However, in the presence of TNFα in cultured adipocytes, SCO induced anti-lipolytic changes in phosphorylation of hormone sensitive lipase and perilipin. Together, these data suggest that the anti-lipolytic effects of SCO on adipose tissue play a role in the ability of this botanical extract to improve whole-body metabolic parameters, and support its use as a dietary supplement to promote metabolic resiliency.Keywords
Funding Information
- National Center for Complementary & Integrative Health (P50AT002776)
- Office of Dietary Supplements (ODS) (P50AT002776)
This publication has 69 references indexed in Scilit:
- Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathwayMetabolism, 2013
- Cyber-T web server: differential analysis of high-throughput dataNucleic Acids Research, 2012
- Characterization of murine melanocortin receptors mediating adipocyte lipolysis and examination of signalling pathways involvedMolecular and Cellular Endocrinology, 2011
- Regulation of fat specific protein 27 by isoproterenol and TNF-α to control lipolysis in murine adipocytesJournal of Lipid Research, 2011
- The citrus flavonoids hesperetin and naringenin block the lipolytic actions of TNF-α in mouse adipocytesBiochemical and Biophysical Research Communications, 2010
- Tpl2 Kinase Is Upregulated in Adipose Tissue in Obesity and May Mediate Interleukin-1β and Tumor Necrosis Factor-α Effects on Extracellular Signal–Regulated Kinase Activation and LipolysisDiabetes, 2009
- TNF‐α and adipocyte biologyFEBS Letters, 2007
- Targets for TNF-α-induced lipolysis in human adipocytesBiochemical and Biophysical Research Communications, 2004
- Down-regulation of cyclic-nucleotide phosphodiesterase 3B in 3T3-L1 adipocytes induced by tumour necrosis factor α and cAMPBiochemical Journal, 2000
- Identification and role of the basal phosphorylation site on hormone‐sensitive lipaseEuropean Journal of Biochemistry, 1990